skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

LYNCH, Thomas J ; BONDARENKO, Igor ; RECK, Martin ; LUFT, Alexander ; SERWATOWSKI, Piotr ; BARLESI, Fabrice ; CHACKO, Raju ; SEBASTIAN, Martin ; NEAL, Joel ; HAOLAN LU ; CUILLEROT, Jean-Marie

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2046-2054 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Fuchs, Charles S, Dr Prof ; Tomasek, Jiri, MD ; Yong, Cho Jae, Prof ; Dumitru, Filip, MD ; Passalacqua, Rodolfo, MD ; Goswami, Chanchal, Prof ; Safran, Howard, Prof ; dos Santos, Lucas Vieira, MD ; Aprile, Giuseppe, MD ; Ferry, David R, Prof ; Melichar, Bohuslav, Prof ; Tehfe, Mustapha, MD ; Topuzov, Eldar, Prof ; Zalcberg, John Raymond, Prof ; Chau, Ian, MD ; Campbell, William, Prof ; Sivanandan, Choondal, MD ; Pikiel, Joanna, MD ; Koshiji, Minori, MD ; Hsu, Yanzhi, PhD ; Liepa, Astra M, PharmD ; Gao, Ling, PhD ; Schwartz, Jonathan D, MD ; Tabernero, Josep, MD

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

SEQUIST, Lecia V ; YANG, James Chih-Hsin ; SU, Wu-Chou ; BENNOUNA, Jaafar ; KATO, Terufumi ; GORBUNOVA, Vera ; KI HYEONG LEE ; SHAH, Riyaz ; MASSEY, Dan ; ZAZULINA, Victoria ; SHAHIDI, Mehdi ; SCHULER, Martin ; YAMAMOTO, Nobuyuki ; O'BYRNE, Kenneth ; HIRSH, Vera ; MOK, Tony ; GEATER, Sarayut Lucien ; ORLOV, Sergey ; TSAI, Chun-Ming ; BOYER, Michael

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

SOCINSKI, Mark A ; BONDARENKO, Igor ; IGLESIAS, Jose L ; RENSCHLER, Markus F ; KARASEVA, Nina A ; MAKHSON, Anatoly M ; VYNNYCHENKO, Igor ; OKAMOTO, Isamu ; HON, Jeremy K ; HIRSH, Vera ; BHAR, Paul ; HUI ZHANG

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2055-2062 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Material Type:
Artigo 		Adicionar ao Meu Espaço

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

VAN CUTSEM, Eric ; TABERNERO, Josep ; MCKENDRICK, Joe ; POLIKOFF, Jonathan ; TELLIER, Alexia ; CASTAN, Rémi ; ALLEGRA, Carmen ; LAKOMY, Radek ; PRENEN, Hans ; PRAUSOVA, Jana ; MACARULLA, Teresa ; RUFF, Paul ; HAZEL, Guy A. Van ; MOISEYENKO, Vladimir ; FERRY, David

Journal of clinical oncology, 2012-10, Vol.30 (28), p.3499-3506 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

JOHNSON, Philip J ; SHUKUI QIN ; LIGONG LU ; CHAO, Yee ; BOUCHER, Eveline ; HAN, Kwang-Hyub ; PAIK, Seung-Woon ; ROBLES-AVINA, Jorge ; KUDO, Masatoshi ; LUNAN YAN ; SOBHONSLIDSUK, Abhasnee ; KOMOV, Dmitry ; PARK, Joong-Won ; DECAENS, Thomas ; TAK, Won-Young ; JENG, Long-Bin ; LIU, David ; EZZEDDINE, Rana ; WALTERS, Ian ; CHENG, Ann-Lii ; POON, Ronnie T. P ; RAOUL, Jean-Luc ; PHILIP, Philip A ; HSU, Chih-Hung ; HU, Tsung-Hui ; HEO, Jeong ; JIANMING XU

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3517-3524 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

SPIGEL, David R ; ERVIN, Thomas J ; GOVINDAN, Ramaswamy ; PATEL, Taral ; ORLOV, Sergey V ; WERTHEIM, Michael S ; WEI YU ; JIPING ZHA ; YAUCH, Robert L ; PATEL, Premal H ; PHAN, See-Chun ; PETERSON, Amy C ; RAMLAU, Rodryg A ; DANIEL, Davey B ; GOLDSCHMIDT, Jerome H ; BLUMENSCHEIN, George R ; KRZAKOWSKI, Maciej J ; ROBINET, Gilles ; GODBERT, Benoit ; BARLESI, Fabrice

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4105-4114 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Cortes, Javier, MD ; O'Shaughnessy, Joyce, MD ; Loesch, David, MD ; Blum, Joanne L, MD ; Vahdat, Linda T, MD ; Petrakova, Katarina, MD ; Chollet, Philippe, MD ; Manikas, Alexey, MD ; Diéras, Veronique, MD ; Delozier, Thierry, MD ; Vladimirov, Vladimir, MD ; Cardoso, Fatima, MD ; Koh, Han, MD ; Bougnoux, Philippe, MD ; Dutcus, Corina E, MD ; Seegobin, Seth, MSc ; Mir, Denis, MSc ; Meneses, Nicole, MSHS ; Wanders, Jantien, MD ; Twelves, Chris, Prof

The Lancet (British edition), 2011-03, Vol.377 (9769), p.914-923 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

Heiss, Markus M. ; Murawa, Pawel ; Koralewski, Piotr ; Kutarska, Elzbieta ; Kolesnik, Olena O. ; Ivanchenko, Vladimir V. ; Dudnichenko, Alexander S. ; Aleknaviciene, Birute ; Razbadauskas, Arturas ; Gore, Martin ; Ganea‐Motan, Elena ; Ciuleanu, Tudor ; Wimberger, Pauline ; Schmittel, Alexander ; Schmalfeldt, Barbara ; Burges, Alexander ; Bokemeyer, Carsten ; Lindhofer, Horst ; Lahr, Angelika ; Parsons, Simon L.

International journal of cancer, 2010-11, Vol.127 (9), p.2209-2221 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
10
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial

MOTZER, Robert J ; NOSOV, Dmitry ; KOGAN, Mikhail ; ALEKSEEV, Boris Y ; STERNBERG, Cora N ; SZCZYLIK, Cezary ; CELLA, David ; IVANESCU, Cristina ; KRIVOSHIK, Andrew ; STRAHS, Andrew ; ESTEVES, Brooke ; BERKENBLIT, Anna ; EISEN, Timothy ; HUTSON, Thomas E ; BONDARENKO, Igor ; LESOVOY, Vladimir ; LIPATOV, Oleg ; TOMCZAK, Piotr ; LYULKO, Oleksiy ; ALYASOVA, Anna ; HARZA, Mihai

Journal of clinical oncology, 2013-10, Vol.31 (30), p.3791-3799 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (4.077)

Idioma 

  1. Inglês  (1.995)
  2. Japonês  (121)
  3. Serbian  (4)
  4. Búlgaro  (4)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.